Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0492 - REMDESIVIR [100 MG; PÓ CONC SOL INJ; FRS]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.